title: Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
authors.affiliation: The Prostate Centre, London, UK. bjui@theprostatecentre.com
authors.forename: Roger S
authors.initials: RS
authors.lastname: Kirby
authors.forename: John M
authors.initials: JM
authors.lastname: Fitzpatrick
mesh_terms: D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D011471:Prostatic Neoplasms / Q000628:therapy*; D012307:Risk Factors